334 related articles for article (PubMed ID: 2542902)
1. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
Kuppuswamy M; Subramanian T; Srinivasan A; Chinnadurai G
Nucleic Acids Res; 1989 May; 17(9):3551-61. PubMed ID: 2542902
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
Arya SK
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
[TBL] [Abstract][Full Text] [Related]
3. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
[TBL] [Abstract][Full Text] [Related]
4. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
5. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.
Green M; Loewenstein PM
Cell; 1988 Dec; 55(6):1179-88. PubMed ID: 2849509
[TBL] [Abstract][Full Text] [Related]
6. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
[TBL] [Abstract][Full Text] [Related]
7. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
Elangovan B; Subramanian T; Chinnadurai G
J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
[TBL] [Abstract][Full Text] [Related]
8. Role of the cysteine-rich region of HIV tat protein on its trans-activational ability.
Kubota S; Endo S; Maki M; Hatanaka M
Virus Genes; 1989 Mar; 2(2):113-8. PubMed ID: 2541558
[TBL] [Abstract][Full Text] [Related]
9. Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.
Jeyapaul J; Reddy MR; Khan SA
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7030-4. PubMed ID: 2205850
[TBL] [Abstract][Full Text] [Related]
10. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
11. Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev.
Subramanian T; Kuppuswamy M; Venkatesh L; Srinivasan A; Chinnadurai G
Virology; 1990 May; 176(1):178-83. PubMed ID: 2184574
[TBL] [Abstract][Full Text] [Related]
12. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1.
Viglianti GA; Mullins JI
J Virol; 1988 Dec; 62(12):4523-32. PubMed ID: 2846868
[TBL] [Abstract][Full Text] [Related]
13. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
14. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
Rappaport J; Lee SJ; Khalili K; Wong-Staal F
New Biol; 1989 Oct; 1(1):101-10. PubMed ID: 2562188
[TBL] [Abstract][Full Text] [Related]
15. Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).
Siderovski DP; Matsuyama T; Frigerio E; Chui S; Min X; Erfle H; Sumner-Smith M; Barnett RW; Mak TW
Nucleic Acids Res; 1992 Oct; 20(20):5311-20. PubMed ID: 1437550
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression.
Green M; Ishino M; Loewenstein PM
Cell; 1989 Jul; 58(1):215-23. PubMed ID: 2752420
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.
Reddy MV; Desai M; Jeyapaul J; Prasad DD; Seshamma T; Palmeri D; Khan SA
Oncogene; 1992 Sep; 7(9):1743-8. PubMed ID: 1501886
[TBL] [Abstract][Full Text] [Related]
18. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
Venkatesh LK; Chinnadurai G
J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
[TBL] [Abstract][Full Text] [Related]
19. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
20. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
Kao SY; Calman AF; Luciw PA; Peterlin BM
Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
